Global Airway Management Devices Market Analysis

The Global Airway Management Devices Market size stood at around xx Bn in 2023 and is projected to reach US $xx Bn by 2033, exhibiting a CAGR of xx% during the forecast period.

The Global Airway Management Devices Market Executive Summary

Airway management entails the assessment, planning and the application of a variety of medical interventions and tools in order to establish the patency or the restoration of airway for effective oxygenation and ventilation. These procedures are required in patients with a compromised airway, respiratory distress, or failure.

Technological development, the growth in diseases affecting the respiratory system, and the growing number of surgical operations are some factors driving the market for airway management devices. The important factors include the necessity for proper management of the airway and new devices like video laryngoscopes which increase safety of surgical and emergency procedures. The market classified by product type includes infraglottic and supraglottic devices, resuscitators and accessories when key companies are Medtronic and Teleflex. Obstacles include legal framework, cost barriers, and a requirement for specialists. As technologies are advancing in the future, some of the impending trends include less invasiveness in surgeries, making of portable devices and integrating artificial intelligence in the healthcare for enhancing both the patient results and the efficacy of the devices.    

Global Airway Management Devices Market Dynamics

Market Growth Drivers

The prevalence of respiratory illnesses such as asthma, COPD, and obstructive sleep apnea warrants proper management of airway in order to facilitate adequate oxygenation. An increase in the number of surgeries as a result of a growing population as well as advancement in medical procedures for patients also significantly drives the demand for devices used during operations such as anaesthesia and management of the airway. Concerning  the factors that drive the market growth, it has been noted that an increase in the proportion of people aged 65 and above, the prevalence of life-style related disorders including obesity, the growth in the emergency medical transport services, and an emphasis on pediatric care have equally propelled the market’s growth. 

Opportunity

Some of the trends in the airway management devices market include identifying new markets such as Asia-Pacific and Latin Americas because of improvements in healthcare and increased purchasing power among patients. Opportunities are present in areas like newer and improved video laryngoscopes, smart monitoring, minimal access options, and disposable products. Also, the ageing apart from having a large population is a specialty care while the specialty care which is pediatrics also shows promising growth. 

Market Restraints

Expense, restricted coverage policies, and regulatory requirements can hinder the incorporation of improved airway management devices, particularly in the developing world. Further, the lack of qualified specialists, issues related to risks in potential complications, and restricted acceptance of such technologies can also affect market growth and the usage of these technologies. 

Competitive Landscape for Airway Management Devices Market in Global

Key Players

• Medtronic plc
• Teleflex Incorporated 
• Ambu A/S
• Smith’s Medical, Inc.
• KARL STORZ SE & Co. KG
• Flexicare (Group) Limited

Recent Developments

June 2023, Airway Management, leading innovator in sleep therapy products and manufacturer of the most globally researched custom oral appliances, announced the launch of its Morf Nasal CPAP Mask. Designed to enhance comfort and sustainability, this revolutionary mask incorporates a silicone-free biodegradable seal, setting a new standard in the industry.

May 2023, Launch of ALNEST N1 Silent mask. Intended for all patients requiring non-invasive ventilation at home, and more particularly for patients treated with CPAP for Sleep Apnea, this mask has been designed to provide maximum comfort, stability and ease of use. Its landmarks and its silent leak system offer an optimal therapeutic experience.

March 2023, BHV Partners  launched  Conus Airway, a startup focused on developing medical devices for respiratory tract anesthesia and surgery. These devices enable simultaneous endotracheal dilation and ventilation, aiming to reduce surgical risks, improve outcomes, minimize cross-contamination, and enhance efficiency in managing respiratory surgeries.

May 2021, Olympus received FDA 510(k) clearance for its Airway Mobilescopes (MAF-TM2, MAF-GM2, and MAF-DM2), allowing healthcare providers to perform various upper and lower airway management procedures. These devices are designed for anesthesiologists, pulmonologists, and critical care providers, offering benefits such as portability, digital capture capability, and a compact all-in-one design.

May 2021, Medtronic announced the U.S. commercial launch of the SonarMed airway monitoring system. The system utilises acoustic technology to check for endotracheal tube (ETT) obstruction and verify position in real-time.

Mergers and Acquisitions

March 2024, Medline, a market-leading manufacturer and supplier of medical supplies and solutions, announced successful acquisition of the manufacturing rights and intellectual property of AG Cuffill from Hospitech Respiration Ltd. The compact and intuitive syringe-like device provides an accurate solution for measuring both pressure and volume of airway cuffs in all clinical settings.

October 2023, The Private Equity team advised SunMed Group Holdings d/b/a AirLife, a portfolio company of Frazier Healthcare Partners, on the completion of its acquisition of Avanos Medical, including the BALLARD, MICROCUFF and endOclear product lines.

September 2023, Inogen Completes Acquisition of Physio-Assist. Acquisition expands inogen’s global respiratory care presence by addressing the sizeable, growing and underserved airway clearance market opportunity.

March 2023, Sunmed was to acquire respiratory & anaesthesia consumables business of Vyaire medical.

Healthcare Policies and Regulatory Landscape for Airway Management Devices Market in Global

Policy changes and Reimbursement scenario

Regulatory approval procedures in developed markets such as the US and Europe demand thorough testing, and this prolongs product development and escalates costs. Standards also change over time, which means that manufacturers will always have to incur costs in order to meet the prevailing ones. Reimbursement has its policies; where there is a favourable coverage policy advocated for establishment of post operative care in fully developed health systems, the absence of such framework in developing markets denies the product due to exorbitant out of pocket expense. Furthermore, possible future adjustments to reimbursement rates and the transition to value-based care initiatives may necessitate cost justification from manufacturers in order to continue growing a lucrative market.